Literature DB >> 22046602

A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.

Jennifer King, Matthew McCall, Anthony Cannella, Michael Anne Markiewicz, Amanda James, Chantelle B Hood, Edward P Acosta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22046602     DOI: 10.1097/qai.0b013e31820eefbe

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  1 in total

1.  The critical need for alternative antiretroviral formulations, and obstacles to their development.

Authors:  Susan Swindells; Charles Flexner; Courtney V Fletcher; Jeffrey M Jacobson
Journal:  J Infect Dis       Date:  2011-07-25       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.